1 completed, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
Follow Jacob Pontoppidan Thyssen: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO) Roflumilast 500 Mcg Oral Tablet, Placebo - Chronic Hand Eczema | Phase 4 | Completed | Jacob Pontoppidan Thyssen | 41 | 2023-09-25 | 2026-08-06 |
| Staphylococcus Aureus and The Skin Microbiome During Flare And Resolution Of Atopic Dermatitis Dicloxacillin Oral Capsule, Elocon 0.1 % Topical Cream - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 4 | Unknown | Jacob Pontoppidan Thyssen | 45 | 2022-10-24 | 2022-12-21 |
Dermatitis, Atopic (1) · Staphylococcal Infections (1)
Dicloxacillin (1) · Mometasone Furoate (1) · Roflumilast (1) · Tablets (1)
Denmark (2)
Jacob Thyssen, Professor, MD, DMSc (1)